TMIGD2 Inhibitors
TMIGD2 inhibitors encompass a range of compounds that, through their actions on different pathways, can lead to the indirect downregulation or functional inhibition of the protein TMIGD2. Cyclosporin A and FK506, for instance, are immunosuppressive agents that inhibit calcineurin, which is crucial for the activation of the transcription factor NFAT. NFAT is involved in the expression of a plethora of genes, including those that could regulate TMIGD2. As such, the inhibition of NFAT by these compounds can decrease cytokine production and potentially suppress TMIGD2 expression or activity within the immune system. Similarly, rapamycin's inhibition of mTOR acts to block T cell activation and proliferation, which can subsequently lead to a reduction in TMIGD2 levels, considering that protein synthesis and cell growth are tightly coupled in activated immune cells.
Furthermore, the PI3K/Akt/mTOR signaling pathway is a central conduit for signals that promote cell survival, growth, and proliferation. Compounds such as LY294002 and Wortmannin, which inhibit PI3K, can disrupt this pathway, leading to reduced survival signals and potentially lower levels of TMIGD2 as cells undergo programmed cell death. Inhibition of MEK1/2 by U0126 and PD98059 results in the blockade of the MAPK/ERK pathway, a route that is critical for cell differentiation and proliferation. Reduced activity within this pathway can indirectly affect TMIGD2 expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin inhibitor that prevents the dephosphorylation and translocation of NFAT to the nucleus. Inhibition of NFAT reduces the expression of cytokines, which can lead to downregulation of TMIGD2 by reducing its activation signals in immune cells. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Macrolide compound that inhibits calcineurin similarly to Cyclosporin A, leading to decreased NFAT activity and thus potentially diminishing TMIGD2 expression or function in T cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that blocks T cell activation and proliferation. By inhibiting mTOR, the downstream effect can lead to reduced expression of proteins including TMIGD2 as a consequence of T cell inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of PI3K, which is upstream of the Akt/mTOR pathway. Inhibition of this pathway can result in reduced cellular survival signals, potentially leading to decreased TMIGD2 levels as cells undergo apoptosis. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, which are upstream kinases in the MAPK/ERK pathway. Inhibition of this pathway can result in decreased cellular proliferation and differentiation signals, indirectly reducing TMIGD2 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that blocks the activation of MAPK/ERK pathway, leading to similar effects as U0126, potentially causing a downregulation of TMIGD2 due to reduced proliferation signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can suppress the JNK signaling pathway, which is involved in stress responses and apoptosis. Inhibition of JNK signaling can lead to reduced TMIGD2 expression as part of a broader cellular response to stress. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that reduces inflammation and cell stress responses. Inhibiting p38 MAPK can lower the expression of TMIGD2 by decreasing the inflammatory signaling that might upregulate its expression. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that can decrease signaling through pathways that promote survival and proliferation, potentially leading to reduced levels of TMIGD2 as a part of altered cellular responses. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor more potent and less selective than LY294002, leading to broad inhibition of the PI3K/Akt pathway and potentially causing decreased expression of TMIGD2 in cells with inhibited growth signals. | ||||||